Markets:

Overview

News

Currencies

International

Treasuries

Femasys Inc. - Common Stock (NQ:FEMY)

0.5683 -0.0047 (-0.82%)

Streaming Delayed Price Updated: 3:02 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Femasys Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Femasys Inc. to Showcase FemCerv at the Annual Meeting for the American Society for Colposcopy and Cervical Pathology

May 01, 2023

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 24, 2023

Via Benzinga

Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results ↗

April 19, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 19, 2023

Via Benzinga

Chardan Capital Maintains Buy Rating for Femasys: Here's What You Need To Know ↗

March 31, 2023

Via Benzinga

Femasys's Return On Capital Employed Overview ↗

March 31, 2023

Via Benzinga

Looking Into Femasys's Return On Capital Employed ↗

December 20, 2022

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

Femasys Announces $3.9 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

April 19, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemaSeed Localized Directional Insemination for Infertility Receives Product Approval in Canada

April 18, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Announces Financial Results for the Year Ended December 31, 2022 and Provides Corporate Update

March 30, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. to Participate in “The Post-Roe Fertility Journey” Panel Discussion at SXSW 2023

March 09, 2023

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 30, 2022

Via Benzinga

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

Exxon Mobil To Rally Around 19%? Here Are 5 Other Price Target Changes For Friday ↗

November 11, 2022

Via Benzinga

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update

November 10, 2022

From Femasys Inc.

Via GlobeNewswire

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control

October 06, 2022

Company remains on track to file an investigational device exemption (IDE) for a pivotal trial to support a pre-market authorization (PMA) in the first quarter of 2023

From Femasys Inc.

Via GlobeNewswire

Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday ↗

October 10, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team

September 29, 2022

From Femasys Inc.

Via GlobeNewswire

Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session ↗

October 07, 2022

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.

Via Benzinga

Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session ↗

August 22, 2022

Losers

Via Benzinga

Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday ↗

August 23, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 16, 2022

Via Benzinga

This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗

August 01, 2022

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings...

Via Benzinga

How Does The Abortion Ban Affect Birth Control Stocks? ↗

July 05, 2022

The debate over abortion reignited in the US following the Supreme Court’s decision to overturn the landmark 1973 Roe v. Wade ruling that generally protects women’s rights to abortion.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.